These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 12387700)

  • 41. [The role of endocannabinoid system in physiological and pathological processes in the eye].
    Nadolska K; Goś R
    Klin Oczna; 2008; 110(10-12):392-6. PubMed ID: 19195174
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plant, synthetic, and endogenous cannabinoids in medicine.
    Di Marzo V; Petrocellis LD
    Annu Rev Med; 2006; 57():553-74. PubMed ID: 16409166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cannabinoids and neuronal damage: differential effects of THC, AEA and 2-AG on activated microglial cells and degenerating neurons in excitotoxically lesioned rat organotypic hippocampal slice cultures.
    Kreutz S; Koch M; Ghadban C; Korf HW; Dehghani F
    Exp Neurol; 2007 Jan; 203(1):246-57. PubMed ID: 17010339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The cannabinoids: an overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy, in appetite promotion, in multiple sclerosis and in neuroprotection.
    Mechoulam R; Hanu L
    Pain Res Manag; 2001; 6(2):67-73. PubMed ID: 11854768
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of cannabinoids in multiple sclerosis.
    Zajicek JP; Apostu VI
    CNS Drugs; 2011 Mar; 25(3):187-201. PubMed ID: 21323391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cannabinoids for gastrointestinal diseases: potential therapeutic applications.
    Di Carlo G; Izzo AA
    Expert Opin Investig Drugs; 2003 Jan; 12(1):39-49. PubMed ID: 12517253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cannabinoids and Neurogenesis: The Promised Solution for Neurodegeneration?
    Valeri A; Mazzon E
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684894
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.
    García C; Gómez-Cañas M; Burgaz S; Palomares B; Gómez-Gálvez Y; Palomo-Garo C; Campo S; Ferrer-Hernández J; Pavicic C; Navarrete C; Luz Bellido M; García-Arencibia M; Ruth Pazos M; Muñoz E; Fernández-Ruiz J
    J Neuroinflammation; 2018 Jan; 15(1):19. PubMed ID: 29338785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cannabinoids in clinical practice.
    Williamson EM; Evans FJ
    Drugs; 2000 Dec; 60(6):1303-14. PubMed ID: 11152013
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development.
    Pertwee RG
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1553-71. PubMed ID: 11060760
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The endocannabinoid nervous system: unique opportunities for therapeutic intervention.
    Porter AC; Felder CC
    Pharmacol Ther; 2001 Apr; 90(1):45-60. PubMed ID: 11448725
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.
    Aymerich MS; Aso E; Abellanas MA; Tolon RM; Ramos JA; Ferrer I; Romero J; Fernández-Ruiz J
    Biochem Pharmacol; 2018 Nov; 157():67-84. PubMed ID: 30121249
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cannabinoids in Medicine: Cancer, Immunity, and Microbial Diseases.
    Śledziński P; Nowak-Terpiłowska A; Zeyland J
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383838
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids.
    Pryce G; Riddall DR; Selwood DL; Giovannoni G; Baker D
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):281-92. PubMed ID: 25537576
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Established and potential therapeutic applications of cannabinoids in oncology.
    Walsh D; Nelson KA; Mahmoud FA
    Support Care Cancer; 2003 Mar; 11(3):137-43. PubMed ID: 12618922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cannabinoids as potential anti-epileptic drugs.
    Smith PF
    Curr Opin Investig Drugs; 2005 Jul; 6(7):680-5. PubMed ID: 16044663
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection.
    Nucci C; Bari M; Spanò A; Corasaniti M; Bagetta G; Maccarrone M; Morrone LA
    Prog Brain Res; 2008; 173():451-64. PubMed ID: 18929127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cannabinoids: between neuroprotection and neurotoxicity.
    Sarne Y; Mechoulam R
    Curr Drug Targets CNS Neurol Disord; 2005 Dec; 4(6):677-84. PubMed ID: 16375685
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Brief Background on Cannabis: From Plant to Medical Indications.
    Klumpers LE; Thacker DL
    J AOAC Int; 2019 Mar; 102(2):412-420. PubMed ID: 30139415
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endocannabinoids and basal ganglia functionality.
    Fernández-Ruiz J; Lastres-Becker I; Cabranes A; González S; Ramos JA
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):257-67. PubMed ID: 12052041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.